Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stem Cell Mobilization Therapy

Known as: Mobilization Therapy 
Therapy to cause release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of collection.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation
The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation 
  • figure 1
  • table 1
  • table 2
Highly Cited
2009
Highly Cited
2009
Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian…
CD34+ peripheral blood hematopoietic stem cells (HSC) are usually collected following mobilization therapy accomplished by using… Expand
Highly Cited
2008
Highly Cited
2008
Lung Insufflation Capacity in Neuromuscular Disease
Bach JR, Mahajan K, Lipa B, Saporito L, Goncalves M, Komaroff E: Lung insufflation capacity in neuromuscular disease. Am J Phys… Expand
Highly Cited
2008
Highly Cited
2008
Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.
BACKGROUND Liver cirrhosis represents the end stage of chronic liver injury. Currently, liver transplantation provides the only… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Highly Cited
2007
Highly Cited
2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
In a phase III randomized, multicenter study, the German-speaking Myeloma-Multicenter Group (GMMG) and the Dutch-Belgian Hemato… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2005
Highly Cited
2005
Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution.
Acute renal failure and tubular cell loss as a result of ischemia constitute major challenges in renal pathophysiology… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Highly Cited
1999
Highly Cited
1999
Fibroblast responses to variation in soft tissue mobilization pressure.
UNLABELLED Augmented soft tissue mobilization therapy (ASTM), a newly developed massage therapy, has been successfully used in… Expand
Highly Cited
1997
Highly Cited
1997
Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.
The purpose of this study was to compare the ability to collect human bone marrow-derived mesenchymal (stromal) progenitor cells… Expand
Highly Cited
1996
Highly Cited
1996
When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood.
PURPOSE To evaluate whether the CD34+ yield from a single peripheral-blood stem-cell (PBSC) harvest could be predicted by… Expand
Highly Cited
1996
Highly Cited
1996
IN VIVO MOBILIZATION OF KARYOTyPICALLY NORMAL PERIPHERAL BLOOD PROGENITOR CELLS IN HIGH‐RISK MDS, SECONDARY OR THERAPY‐RELATED ACUTE MYELOGENOUS LEUKAEMIA
We have previously reported that mobilization of Philadelphia (Ph) chromosome‐negative progenitors is possible in a significant… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE